Sebastian Kobold

60PUBLICATIONS

346CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunityProteomics and intermolecular interactions (excl. medical proteomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (60)

Sort by Publication Date:

|Jun 29, 2026

The evolving role of cytokines for CAR-T cell manufacturing and beyond.

|Jun 01, 2026

TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

|Feb 27, 2026

NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumors.

Dominik Humer, Victoria Klepsch, Dietmar Rieder

|Feb 24, 2026

FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler

|Feb 11, 2026

Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.

Janina Dörr, Lisa Gregor, Sebastian B Lacher

|Jan 22, 2026

RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma.

Anne Marie Senz, Bruno L Cadilha, Julia Teppert

Pageof 10

Frequent Collaborators

14 joint publications

Adrian Gottschlich

10 joint publications

Stefan Endres

9 joint publications

Sophia Stock

8 joint publications

Florian Märkl

7 joint publications

Bruno Loureiro Cadilha

Matthias Seifert

Daria Briukhovetska

Ruth Grünmeier

Christian Klein

Theo Lorenzini

Frequent Collaborators

14 joint publications

Adrian Gottschlich

10 joint publications

Stefan Endres

9 joint publications

Sophia Stock

8 joint publications

Florian Märkl